Skip to content
    Back to Database
    Ergogenic CompoundsSynthetic

    Creatine Hydrochloride

    Also known as: Cr-HCl, creatine HCl

    Three randomised controlled trials in humans examined oral Cr‑HCl. In resistance‑training young adults, Cr‑HCl produced greater gains in strength, skeletal muscle mass and muscle cross‑sectional area versus placebo and performed similarly to creatine monohydrate. In collegiate soccer players, Cr‑HCl improved short‑term power and sprint‑related adaptations versus placebo and showed larger gains than creatine monohydrate for some performance measures. In perimenopausal/menopausal women, daily Cr‑HCl at 1.5 g for 8 weeks increased frontal brain creatine and improved reaction time and some metabolic markers versus placebo. No severe adverse events were reported in these trials.

    Last reviewed: 2026-10-14 · 3 indexed studies

    Evidence Score
    63/100
    Increase strength and muscle mass alongside resistance trainingSupport short-term high‑intensity exercise performance (sprints, power)Raise brain creatine and target cognition in specific populations
    Data Completeness4/4 · 100%
    Evidence ScoreDosageSafetyLinked Studies

    Set your location for accurate regulatory status

    Saved on this device — no sign-in needed.

    Overview

    Creatine hydrochloride (Cr‑HCl) is a soluble creatine salt marketed as an alternative to creatine monohydrate, typically used to support strength, power and muscle mass and occasionally promoted for cognitive effects. Human randomised trials have tested low gram and sub‑gram daily doses over weeks in athletes and middle‑aged women.

    Mechanism & Function

    Mechanism of Action

    As a creatine salt, Cr‑HCl delivers creatine that can be taken up into muscle and brain cells to increase intracellular phosphocreatine and total creatine pools, supporting ATP resynthesis during short, high‑intensity efforts and potentially altering cellular energetics in neural tissue.

    Physiological Role

    Supports cellular energy buffering via the creatine–phosphocreatine system in muscle and brain tissue.

    Primary Pathways

    Phosphocreatine-mediated ATP regenerationCellular energy metabolismIntracellular creatine transport

    Performance / Health Relevance

    By increasing tissue creatine, Cr‑HCl can augment short‑duration, high‑intensity performance (power, sprints) and enhance strength and hypertrophic adaptations when combined with resistance training; it may also raise brain creatine and modestly affect cognition in specific populations.

    Evidence Review

    Overall63/100
    Human Clinical56/100
    Meta-AnalysisN/A

    No meta-analyses or systematic reviews indexed for this ingredient yet.

    Mechanistic90/100
    Real-World44/100
    Safety75/100

    Dimensions marked N/A have no indexed evidence of that class. They are shown as unavailable rather than scored.

    Practical Use & Dosage

    Minimum Effective Dose
    Around 750–1500 mg/day showed central effects in one trial; ~0.03 g/kg/day (~2–3 g/day) was used in resistance‑training trials.
    Optimal Range
    Not firmly established from these trials; studied ranges include 0.75–3 g/day.
    Upper / Caution Level
    Not established for Cr‑HCl specifically; use common creatine guidance for total creatine intake when combining formulations.
    Timing
    Taken orally; timing relative to training varied and was not a focus of the cited trials.
    Best Format
    Oral powder or capsules.
    Bioavailability
    Cr‑HCl is promoted for greater solubility than monohydrate; clinical outcomes in trials were observed at low gram doses.
    Absorption Considerations
    Studies used daily dosing without additional loading protocols; absorption details beyond trial reports are not provided in the abstracts.

    Safety & Interactions

    Side Effects

    • •No severe adverse events reported in cited trials
    • •Gastrointestinal upset has been reported with creatine formulations in other contexts (not specified in these abstracts)

    Contraindications

    • Pre‑existing kidney disease (caution)

    Drug Interactions

    • •Concomitant nephrotoxic medications — exercise caution and monitor renal function

    Who Should Avoid

    • •People with known renal impairment
    • •Pregnant or breastfeeding women (no data in these abstracts)

    Monitoring

    Consider baseline and periodic renal function testing if there are risk factors for kidney disease or if taking other nephrotoxic agents.

    Frequently Asked Questions

    Auto-generated from indexed evidence — dosage, safety, interactions, and more.

    When is Creatine Hydrochloride typically used or indicated?

    Creatine Hydrochloride is most commonly used for: Increase strength and muscle mass alongside resistance training, Support short-term high‑intensity exercise performance (sprints, power), Raise brain creatine and target cognition in specific populations. Supports cellular energy buffering via the creatine–phosphocreatine system in muscle and brain tissue.

    How does Creatine Hydrochloride work?

    As a creatine salt, Cr‑HCl delivers creatine that can be taken up into muscle and brain cells to increase intracellular phosphocreatine and total creatine pools, supporting ATP resynthesis during short, high‑intensity efforts and potentially altering cellular energetics in neural tissue.

    What is the recommended dose of Creatine Hydrochloride?

    The optimal range is Not firmly established from these trials; studied ranges include 0.75–3 g/day.. with a minimum effective dose of Around 750–1500 mg/day showed central effects in one trial; ~0.03 g/kg/day (~2–3 g/day) was used in resistance‑training trials.. Best taken: Taken orally; timing relative to training varied and was not a focus of the cited trials.. Upper / caution level: Not established for Cr‑HCl specifically; use common creatine guidance for total creatine intake when combining formulations..

    What are the side effects of Creatine Hydrochloride?

    Reported side effects include: No severe adverse events reported in cited trials; and Gastrointestinal upset has been reported with creatine formulations in other contexts (not specified in these abstracts). Monitoring: Consider baseline and periodic renal function testing if there are risk factors for kidney disease or if taking other nephrotoxic agents.

    Does Creatine Hydrochloride interact with medications?

    Known or theoretical interactions: Concomitant nephrotoxic medications — exercise caution and monitor renal function. Always check with a clinician before combining with prescription medication.

    Who should avoid Creatine Hydrochloride?

    Creatine Hydrochloride is generally not recommended for: People with known renal impairment; Pregnant or breastfeeding women (no data in these abstracts); and Pre‑existing kidney disease (caution).

    How strong is the evidence for Creatine Hydrochloride?

    Evidence level: Moderate (overall score 63/100), based on 3 indexed studies on SuppIndex.

    Research & References (3)

    Supplementing With Which Form of Creatine (Hydrochloride or Monohydrate) Alongside Resistance Training Can Have More Impacts on Anabolic/Catabolic Hormones, Strength and Body Composition?

    RCT2024
    PubMed

    Randomised trial in 40 participants (aged 18–25) undergoing 8 weeks resistance training; compared RT+Cr‑HCl (0.03 g/kg), RT+Cr monohydrate (with and without loading), and RT+placebo. Measured strength, body composition, muscle CSA and hormones.

    Creatine formulations and repeated sprint training: effects on physical and physiological adaptations in soccer players during the short-term preparation phase.

    RCT2026
    PubMed

    Randomised trial in 40 collegiate male soccer players over a 4‑week repeated sprint training period comparing creatine monohydrate, creatine ethyl ester, creatine hydrochloride and placebo. Assessed jumps, sprint times, Wingate power and incremental exercise tests.

    The Effects of 8-Week Creatine Hydrochloride and Creatine Ethyl Ester Supplementation on Cognition, Clinical Outcomes, and Brain Creatine Levels in Perimenopausal and Menopausal Women (CONCRET-MENOPA): A Randomized Controlled Trial.

    RCT2026
    PubMed

    Randomised, double‑blind trial in 36 perimenopausal and menopausal women over 8 weeks testing low (750 mg/day), medium (1500 mg/day) Cr‑HCl, Cr‑HCl plus creatine ethyl ester (800 mg/day), and placebo. Assessed cognition, brain creatine, clinical and biochemical markers.

    Related Ingredients

    Other top-rated ingredients in Ergogenic Compounds.

    Research Overview

    Moderate Evidence
    3Total Studies
    3Human Trials
    0Meta-Analyses
    2026Latest Study
    0Animal / In Vitro
    1Athlete Studies
    Primary data sourceGeneral Population
    Pooled evidence (meta-analysis / systematic review)No
    Athlete-specific data1 studies

    Cite this ingredient

    One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.

    Stable URL

    https://thesuppindex.com/ingredients/creatine-hydrochloride

    SuppIndex. (2026). Creatine Hydrochloride: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/creatine-hydrochloride

    Based on 3 indexed studies · Evidence level: Moderate.

    Goal Ratings

    Muscle Gain
    Strength
    Recovery
    Cognition
    Endurance
    General Health

    Stack Compatibility

    Studied both alone and versus creatine monohydrate; total daily creatine from all sources should be considered.

    Creatine monohydrate (studied head‑to‑head)Resistance training programmesStandard sports supplements (protein)